A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
Clinical trial NCT00529581 · COMPLETED
Trial details
- NCT number
- NCT00529581
- Sponsor
- Cognition Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.